Drug Overdose

37 registered clinical trials studyying Drug Overdose — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Justice Community Overdose Innovation Network II TCU Hub NCT07528846	Texas Christian University	N/A
Not Yet Recruiting	Behavioral Safety and Fentanyl Education: BSAFE NCT07219082	San Francisco Department of Public Health	N/A
Recruiting	Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning NCT07193069	Centre Hospitalier de Saint-Denis	—
Recruiting	Social Network Overdose Prevention and Education Intervention NCT06327061	Johns Hopkins Bloomberg School of Public Health	N/A
Active Not Recruiting	Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk NCT05657106	April M Young	N/A
Terminated	Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose NCT05517668	Richard Dart, MD, PhD	Phase 2
Recruiting	CytOSorb TreatMent Of Critically Ill PatientS Registry NCT05146336	CytoSorbents, Inc	—
Unknown	AI to Improve Data From Danish Cardiac Arrest Registry NCT05308303	Prehospital Center, Region Zealand	—
Recruiting	A Setting Focus Overdose Prevention Intervention NCT05320835	Johns Hopkins Bloomberg School of Public Health	N/A
Completed	Preventing Overdose Using Information and Data From the Environment NCT05096429	Brown University	N/A
Withdrawn	Virtual Overdose Response NCT04391192	AHS Cancer Control Alberta	N/A
Completed	The Rhode Island Prescription and Illicit Drug Study NCT04372238	Brown University	N/A
Completed	Use of Virtual Reality for Overdose Management Educational Trainings NCT04091659	University of Pennsylvania	N/A
Unknown	EEG Monitoring in the Emergency Department NCT04070521	Massachusetts General Hospital	—
Unknown	Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose NCT03845699	RTM Vital Signs, LLC	—
Completed	Repeated-dose Behavioral Intervention to Reduce Opioid Overdose NCT03838510	San Francisco Department of Public Health	N/A
Completed	Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal NCT03489161	Virginia Commonwealth University	EARLY_Phase 1
Completed	Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition NCT03533179	University Hospital Bispebjerg and Frederiksberg	Phase 4
Completed	Prescribe to Save Lives NCT03175640	Baystate Medical Center	N/A
Completed	Effectiveness of a Postal Intervention to Improve the Use of PPI NCT03840018	Osakidetza	N/A
Completed	Monitored vs Standard Supplementation of Vitamin D in Preterm Infants NCT03087149	Princess Anna Mazowiecka Hospital, Warsaw, Poland	N/A
Completed	A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses NCT02922959	University of Cincinnati	N/A
Completed	Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol. NCT02924454	Mikkel Bring Christensen	Phase 4
Completed	Primary Care Intervention to Reduce Prescription Opioid Overdoses NCT02464410	VA Office of Research and Development	N/A
Completed	A Usability Assessment of Naloxone by Community Members NCT03309449	State University of New York - Upstate Medical University	N/A
Unknown	Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer Study NCT02733822	King's College London	Phase 1
Completed	Bioavailability of Nasal Naloxone and Injected Naloxone Compared NCT02598856	Norwegian University of Science and Technology	Phase 1
Completed	Pharmacodynamics and Arteriovenous Differences of Naloxone in Healthy Participants Exposed to an Opioid NCT02405988	Norwegian University of Science and Technology	N/A
Completed	Pharmacokinetics and Pharmacodynamics of a New Formulation of Nasal Naloxone for Prehospital Use NCT02307721	Norwegian University of Science and Technology	Phase 1 / Phase 2
Completed	Safety and Health Intervention Project NCT02152397	University of Michigan	N/A
Completed	Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers NCT02572089	National Institute on Drug Abuse (NIDA)	Phase 1
Completed	Phone Interview to Prevent Recurring Opioid Overdoses NCT02282306	University of Cincinnati	N/A
Completed	Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients NCT02093559	San Francisco Department of Public Health	N/A
Completed	Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use NCT02158117	Norwegian University of Science and Technology	Phase 1
Unknown	Nasal Naloxone for Narcotic Overdose NCT01912573	Judith Feinberg	Phase 4
Completed	A Pilot Study of the Bioavailability of Nasal Naloxone NCT01939444	Norwegian University of Science and Technology	Phase 2
Completed	Safety & Prevention Outcomes Study NCT01894087	University of Michigan	N/A